Skorpios Trust

13F Holdings History for Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

Symbol: STOK on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 2.26M shares
Security Ownership: 4.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Montrago Trustees Ltd ownership in Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

2025-08-26 - Montrago Trustees Ltd has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.26M shares of Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK). This represents 4.1% percent ownership of the company. In their previous filing dated 2025-06-23, Skorpios Trust had reported owning 3.26M shares, indicating a decrease of -30.7% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Montrago Trustees Ltd	4.1%	-31.7%	$44.6M	2.26M	-1,000,000	-30.7%	$19.77	13D/A	8/22/2025	26 Aug 2025 17:42:26
Montrago Trustees Ltd	6%	-17.1%	$29.1M	3.26M	-650,000	-16.6%	$8.93	13D/A	6/18/2025	23 Jun 2025 16:47:25
Montrago Trustees Ltd	7.2%	-44.6%	$34.9M	3.91M	-3,000,000	-43.4%	$8.93	13D/A	6/4/2025	6 Jun 2025 16:23:10
Skorpios Trust	13%		$48.5M	6.91M			$7.02	13D/A	12/23/2024	27 Dec 2024 17:23:14

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	99.7%	-44.2%	$53M	2.26M	-1,000,000	-30.7%	$23.50	Q3 2025
6/30/2025	99.6%	-112%	$37M	3.26M	-3,650,000	-52.9%	$11.35	Q2 2025
3/31/2025	99.7%		$45.9M	6.91M			$6.65	Q1 2025
12/31/2024	99.8%	-28.9%	$76.2M	6.91M	-2,000,000	-22.5%	$11.03	Q4 2024
9/30/2024	99.8%	-21.7%	$109M	8.91M	-1,937,500	-17.9%	$12.29	Q3 2024
6/30/2024	99.9%	-24.9%	$146M	10.8M	-3,600,000	-24.9%	$13.51	Q2 2024
3/31/2024	99.9%		$195M	14.4M			$13.50	Q1 2024
12/31/2023	99.8%		$76M	14.4M			$5.26	Q4 2023
9/30/2023	99.8%		$56.9M	14.4M			$3.94	Q3 2023
6/30/2023	66.7%		$154M	14.4M			$10.63	Q2 2023
3/31/2023	48.6%		$120M	14.4M			$8.33	Q1 2023
12/31/2022	42.4%		$133M	14.4M			$9.23	Q4 2022
9/30/2022	52.3%		$185M	14.4M			$12.84	Q3 2022
6/30/2022	79.8%		$191M	14.4M			$13.21	Q2 2022
3/31/2022	81%		$304M	14.4M			$21.05	Q1 2022
12/31/2021	76.7%		$347M	14.4M			$23.99	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.